Answers are grounded in this paper and cite their sources.
This randomized, double-blind exploratory clinical study evaluated the plaque-inhibiting efficacy of dextranase-containing toothpastes, with or without isopropyl methylphenol (IPMP), compared to a control toothpaste lacking these reagents. Participants were randomly assigned using a computer-generated list, stratified by baseline plaque index (PI), age, and gender. The primary outcome was the change in the mean PI from baseline, measured using the Turesky modification of the Quigley–Hein index at weeks 2, 4, and 8. Overall plaque status and treatment effects were assessed longitudinally. A total of 210 participants were enrolled, and 186 completed the study. At weeks 2, 4, and 8, the between-group differences in least-squares mean PI between the Control group and Test group 1 were 0.16, 0.28, and 0.37, respectively (all unadjusted p < 0.0001). The corresponding differences between the Control group and Test group 2 were 0.26, 0.53, and 0.62, respectively (unadjusted p < 0.0001, p < 0.0001, and p < 0.001). The differences between Test groups 1 and 2 were 0.10, 0.25, and 0.25 at weeks 2, 4, and 8, respectively (unadjusted p = 0.0009, p < 0.0001, and p < 0.0001). These exploratory comparisons indicate lower PI values in both test groups than in the Control group and lower PI values in Test group 2 than in Test group 1. In this exploratory randomized trial, dextranase-containing formulations were associated with lower plaque index values than the Control toothpaste over 8 weeks. The formulation containing a higher dextranase level plus IPMP showed the lowest PI values; however, the study design does not allow the independent contribution of IPMP to be determined. This trial was retrospectively registered at ISRCTN (ISRCTN24643598) on August 11, 2025.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: